A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations

NCT07472907 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Cochlear Synaptopathy

Interventions

DRUG: CIL001 (Paliroden)
DRUG: Placebo

Sponsor

Cilcare SAS